We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RSG:NYSERepublic Services, Inc. Analysis

Data as of 2026-06-13 - not real-time

$209.91

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Republic Services posted a solid Q1 2026 performance, with revenue rising 2.6% year‑over‑year to $4.11 billion and non‑GAAP earnings per share beating expectations by 3.8%. The company delivered a 20.2% operating margin and a 13% profit margin, while generating $4.5 billion of operating cash flow and $1.8 billion of free cash flow, supporting a sustainable dividend yield of 1.19% with a 35% payout ratio. Fundamentally, the firm’s ROE of 18.3% and modest revenue growth position it as a stable, cash‑rich business, though a debt‑to‑equity ratio above 100% signals leverage risk.
On the technical side, the stock trades above its 20‑day (207.7) and 50‑day (208.5) moving averages but remains below the 200‑day SMA (216.5), indicating short‑term momentum in a longer‑term bearish context. The MACD histogram is positive and the signal is bullish, yet volume is trending down and 30‑day volatility sits near 24%, suggesting caution. Analyst consensus remains a “Buy” with a median target of $248, implying roughly 16% upside, while a recent downgrade from Argus to “Hold” tempers enthusiasm. Overall, the blend of defensive cash flow, dividend stability, and modest upside is offset by high leverage and softening price momentum.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but decreasing volume
  • Current price near short‑term support levels
  • Dividend provides downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst consensus Buy with ~16% upside to target price
  • Strong cash flow supporting dividend and debt servicing
  • Modest revenue growth and margin expansion

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Defensive waste‑management sector with stable demand
  • High leverage requiring ongoing cash‑flow discipline
  • Sustainable dividend and solid ROE

Key Metrics & Analysis

Financial Health

Revenue Growth2.60%
Profit Margin12.99%
P/E Ratio30.1
ROE18.35%
ROA6.18%
Debt/Equity117.58
P/B Ratio5.4
Op. Cash Flow$4.5B
Free Cash Flow$1.8B
Industry P/E30.6

Technical Analysis

TrendBearish
RSI53.2
Support$197.62
Resistance$218.91
MA 20$207.71
MA 50$208.51
MA 200$216.54
MACDBullish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value$41.68
Target Price$243.58
Upside/Downside16.04%
GradeFair
TypeBlend
Dividend Yield1.19%

Risk Assessment

Beta-0.22
Volatility24.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.